Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Feb 05, 2018 7:00 AM - Feb 07, 2018 3:00 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Regulatory Submissions, Information, and Document Management Forum

Session 4: New FDA Draft Guidance on Part 11 in Clinical Investigations and Mobile Technologies in Clinical Investigations

Session Chair(s)

Ron  Fitzmartin, PhD, MBA

Ron Fitzmartin, PhD, MBA

Senior Advisor, Office of Regulatory Operations, CBER

FDA, United States

This session will review the new 2017 FDA Guidance on 21 CFR Part 11 in Clinical Investigations, the public comments, discuss next steps, and hear from the audience on the topics presented.

Speaker(s)

Cheryl  Grandinetti, PharmD

Part 11 Guidance

Cheryl Grandinetti, PharmD

FDA, United States

Associate Director for Clinical Policy, CDER/OC/OSI/DCCE

Leonard  Sacks, MD

Regulatory Considerations in the Use of Mobile Technology in Clinical Investigations

Leonard Sacks, MD

FDA, United States

Director, Clinical Methodologies,Office of Medical Policy, CDER

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.